Nociception and BIS Level Monitoring in COVID-19 Patients in the Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

December 8, 2022

Study Completion Date

December 8, 2022

Conditions
Nociceptive Pain
Interventions
DEVICE

Nociception Level Monitor (NOL) by Medasense Biometrics Ltd., Israel

"The NOL monitor measures various parameters via a sensor in a finger probe that is attached to the patient.~These parameters are:~* Temperature~* Galvanic skin response~* Accelerometer~* Photoplethysmograph (pulse rate, pulse rate variability, photoplethysmograph amplitude)~All this data is combined in an algorithm which produces a number between 0-100. Between 10-25 indicates adequate analgesia, below 10 too much analgesia, above 25 too little analgesia. No actions are taken based on this measurement."

DEVICE

Bispectral index (BIS)

The BIS processes EEG information to provide a direct measurement of the patient's level of consciousness and insight into the effects of anesthesia on the brain.

OTHER

Questionnaire perception of the nurse on pain patient

The investigators developed a questionnaire with 7-questions regarding the perception of the responsible nurse on the pain of the patient. When the investigators measured for 8 hours with the BIS and the NOL they will ask the nurse what his or her perception was of the pain of the patient. Eventually the investigators will compare the answers of this questionnaire with the NOL and BIS values that they observed, whether the information corresponds or not.

Trial Locations (1)

2333ZA

Leiden University Medical Centre, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER